MedPath

Kineflex|C Artificial Disc System to Treat Cervical Degenerative Disc Disease (DDD)

Not Applicable
Terminated
Conditions
Degenerative Disc Disease (DDD)
Interventions
Device: Artificial disk
Device: Artificial disc
Registration Number
NCT00374413
Lead Sponsor
SpinalMotion
Brief Summary

The purpose of this study is to show that the Kineflex\|C Spinal System is no worse than conventional Anterior Cervical Diskectomy with Fusion (ACDF) in patients with single level degenerative disc disease at any cervical level from C3 to C7.

Detailed Description

The Kineflex\|C disc is a 3-piece modular design consisting of two cobalt chrome molybdenum (CCM) end-plates and a fully articulating CCM core. The system is available in two foot print sizes.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
343
Inclusion Criteria
  • have symptoms of cervical degenerative disc disease (DDD) at only one cervical level from C3 to C7, disc herniation on CT or MRI;
  • have radiculopathy symptoms in neck, one or both shoulders, and/or one or both arms;
  • have at least six months of prior conservative treatment (e.g., physical therapy and/or use of anti-inflammatory medications and muscle relaxants at the manufacturer's recommended therapeutic dose), the presence of progressive symptoms (e.g., increasing numbness or tingling), or signs of nerve root compression;
  • have moderate disability neck disability index (NDI) score; AND
  • be likely to return for all follow-up visits and be willing and able to provide informed consent for study participation
Exclusion Criteria
  • marked cervical instability;
  • non discogenic neck pain or non discogenic source of symptoms;
  • radiographic confirmation of severe facet disease or facet degeneration;
  • bridging osteophytes;
  • prior surgery at the level to be treated;
  • prior fusion at any cervical level;
  • more than one neck surgery via anterior approach;
  • previous trauma to the C3-C7 levels resulting in compression or bursting;
  • documented presence of free nuclear fragment at any cervical level;
  • severe myelopathy;
  • any paralysis;
  • history of chemical or alcohol dependence;
  • active systemic infection;
  • infection at the site of surgery;
  • prior disc space infection or osteomyelitis in the cervical spine;
  • any terminal, systemic or autoimmune disease;
  • metabolic bone disease (e.g., osteoporosis, gout, osteomalacia, Paget's disease);
  • any disease, condition or surgery which might impair healing;
  • known metal allergy;
  • arachnoiditis;
  • currently experiencing an episode of major mental illness;
  • pregnancy at time of enrollment, or planning to become pregnant, since this would contraindicate surgery;
  • morbid obesity; use of spinal stimulator at any cervical level prior to surgery;
  • currently a prisoner;
  • currently involved in spinal litigation which may influence the subjects reporting of symptoms; OR
  • lives more than 300 miles from study center or participation in any other investigational drug, biologic, or medical device study within the last 30 days prior to study surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACDFArtificial disc-
ACDFArtificial disk-
Kineflex-CArtificial disk-
Kineflex-CArtificial disc-
Primary Outcome Measures
NameTimeMethod
Improvement in Neck Disability Index (NDI) Score at 24 months compared with baseline24 months
No major device related adverse events24 months
Secondary Outcome Measures
NameTimeMethod
Disc height at 24 months compared to baseline24 months
Displacement or migration of the device24 months
Clinically significant improvement in one or more radicular symptoms at 24 months compared to baseline24 months
Time to recovery24 months
Adjacent level deterioration at 24 months compared to baseline24 months
Odom's Criteria24 months
Progressive facet disease at 24 months compared to baseline24months

Trial Locations

Locations (21)

Univ. of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Kaiser Foundation Research Institute

🇺🇸

Oakland, California, United States

Rocky Mountain Associates in Orthopedic Medicine, P.C.

🇺🇸

Loveland, Colorado, United States

Sierra Regional Spine Institute

🇺🇸

Reno, Nevada, United States

University of California San Diego

🇺🇸

San Diego, California, United States

Maryland Brain and Spine Center

🇺🇸

Annapolis, Maryland, United States

Orthopaedic Associates, P.A

🇺🇸

Towson, Maryland, United States

William Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Semmes-Murphy Clinic

🇺🇸

Memphis, Tennessee, United States

Tower Orthopedics and Sports Medicine

🇺🇸

Beverly Hills, California, United States

Emory Orthopaedics & Spine Center

🇺🇸

Atlanta, Georgia, United States

Spine Institute of Louisiana

🇺🇸

Shreveport, Louisiana, United States

Hamilton Orthopaedic Surgery and Sports Medicine

🇺🇸

Hamilton, New York, United States

Northern Westchester Hospital

🇺🇸

Mount Kisco, New York, United States

Manhattan Orthopaedics, P.C.

🇺🇸

New York, New York, United States

Carolina Neurosurgery and Spine Associates

🇺🇸

Charlotte, North Carolina, United States

Triangle Orthopaedic Associates, P.A.

🇺🇸

Durham, North Carolina, United States

Plano Orthopedic Sports Medicine & Spine Center

🇺🇸

Plano, Texas, United States

Gordon Spine Associates

🇺🇸

Tyler, Texas, United States

SpineMark CRO at Texas Back Institue

🇺🇸

Plano, Texas, United States

Orthopedics International Spine

🇺🇸

Kirkland, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath